Earnings Call · Q2 FY2022·2022-08-14

Q2 22EPS -18.94%·Rev n/aQ1 22EPS +24.44%·Rev n/aQ4 21EPS +20.00%·Rev n/aQ3 21EPS n/a·Rev n/a⚠ consensus missing

Longeveron Inc. LGVN

Elsie Yau — Investor Relations

Chris Min — Interim Chief Executive Officer and Chief Medical Officer

James Clavijo — Chief Financial Officer

+0.2%1d on move date−1.5% vs SPY3d−0.7%5d−6.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LGVN calls or request research access.

More LGVN calls Browse calls Request research access